We are live on ! Find out more
MXCT icon

MaxCyte

104 hedge funds and large institutions have $376M invested in MaxCyte in 2022 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 45 increasing their positions, 30 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 45 | Existing positions reduced: 30

0% more funds holding in top 10

Funds holding in top 10: 55 (0)

0.88% less ownership

Funds ownership: 68.42%67.54% (-0.88%)

10% less call options, than puts

Call options by funds: $19K | Put options by funds: $21K

4% less funds holding

Funds holding: 108104 (-4)

17% less capital invested

Capital invested by funds: $452M → $376M (-$76.4M)

36% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 11

Holders
104
Holders Change
-4
Holders Change %
-3.7%
% of All Funds
1.67%
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.08%
New
7
Increased
45
Reduced
30
Closed
11
Calls
$19K
Puts
$21K
Net Calls
-$2K
Net Calls Change
-$101K
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of America
26
Bank of America
North Carolina
$2.68M -$1.46M -237,547 -33%
NRC
27
North Run Capital
Massachusetts
$2.47M -$644K -105,000 -19%
Point72 Asset Management
28
Point72 Asset Management
Connecticut
$2.3M +$2.37M +386,157 +1,106%
Lazard Asset Management
29
Lazard Asset Management
New York
$1.95M -$785K -128,043 -26%
N
30
Nuveen
North Carolina
$1.94M -$230K -37,571 -10%
RG
31
Rathbones Group
United Kingdom
$1.93M -$117K -19,014 -5%
Allspring Global Investments
32
Allspring Global Investments
North Carolina
$1.86M +$30.6K +4,989 +1%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$1.78M +$27.6K +4,509 +1%
Citigroup
34
Citigroup
New York
$1.73M -$3.12M -509,486 -61%
JP Morgan Chase
35
JP Morgan Chase
New York
$1.67M +$232K +37,797 +14%
Baillie Gifford & Co
36
Baillie Gifford & Co
United Kingdom
$1.54M +$555K +90,525 +45%
SCM
37
Stonepine Capital Management
Oregon
$1.49M +$1.68M +273,287 New
RA
38
Royce & Associates
New York
$1.47M +$299K +48,800 +22%
PFM
39
Premier Fund Managers
United Kingdom
$1.37M
AMH
40
Apollo Management Holdings
New York
$1.33M
BL
41
Bleichroeder LP
New York
$1.32M
Charles Schwab
42
Charles Schwab
California
$1.27M +$19.5K +3,176 +1%
CAPTRUST Financial Advisors
43
CAPTRUST Financial Advisors
North Carolina
$987K +$494K +80,555 +80%
Swiss National Bank
44
Swiss National Bank
Switzerland
$939K +$28.2K +4,600 +3%
RhumbLine Advisers
45
RhumbLine Advisers
Massachusetts
$699K +$9.1K +1,484 +1%
M&T Bank
46
M&T Bank
New York
$682K +$118K +19,312 +18%
Goldman Sachs
47
Goldman Sachs
New York
$671K -$2.06M -335,480 -73%
William Blair & Company
48
William Blair & Company
Illinois
$642K +$15.3K +2,500 +2%
HSBC Holdings
49
HSBC Holdings
United Kingdom
$608K -$170K -27,650 -20%
New York State Common Retirement Fund
50
New York State Common Retirement Fund
New York
$575K +$25 +4 +0%

MXCT Hedge Fund Activity: Q4 2022 in Review

104 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q4 2022, worth a combined $376M — down 17% from $452M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of MXCT and 7 opened new positions — a net loss of 4 holders — while 30 trimmed existing stakes and 45 added.

The largest buyer was Citadel Advisors, adding an estimated $5.93M. The largest seller was Casdin Capital, cutting an estimated $7.55M.

  • 104 institutional investors held MaxCyte (MXCT) as of Q4 2022, down from 108 in Q3 2022.
  • Funds reported $376M of MaxCyte stock for Q4 2022, down 17% quarter-over-quarter.
  • 7 funds opened new MaxCyte positions in Q4 2022 and 11 closed out, a net change of -4 holders.
  • The largest MaxCyte buyer in Q4 2022 was Citadel Advisors, an estimated $5.93M added.
  • The largest MaxCyte seller in Q4 2022 was Casdin Capital, an estimated $7.55M sold.

Based on aggregated 13F filings for Q4 2022.